Optima Medical Innovations 過去の業績
過去 基準チェック /06
Optima Medical Innovations has been growing earnings at an average annual rate of 1.5%, while the Pharmaceuticals industry saw earnings growing at 27.3% annually. Revenues have been growing at an average rate of 38% per year.
主要情報
1.5%
収益成長率
43.1%
EPS成長率
| Pharmaceuticals 業界の成長 | 23.1% |
| 収益成長率 | 38.0% |
| 株主資本利益率 | -11.6% |
| ネット・マージン | -18.8% |
| 前回の決算情報 | 30 Sep 2021 |
最近の業績更新
Recent updates
収支内訳
Optima Medical Innovations の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
| 日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
|---|---|---|---|---|
| 30 Sep 21 | 2 | 0 | 0 | 0 |
| 30 Jun 21 | 2 | 0 | 0 | 0 |
| 31 Mar 21 | 5 | -3 | 2 | 0 |
| 31 Dec 20 | 5 | -4 | 3 | 0 |
| 30 Sep 20 | 7 | -16 | 6 | 0 |
| 30 Jun 20 | 8 | -18 | 8 | 0 |
| 31 Mar 20 | 6 | -17 | 6 | 0 |
| 31 Dec 19 | 5 | -18 | 7 | 0 |
| 30 Sep 19 | 4 | -11 | 7 | 0 |
| 30 Jun 19 | 3 | -10 | 6 | 0 |
| 31 Mar 19 | 1 | -17 | 9 | 0 |
| 31 Dec 18 | 1 | -16 | 8 | 0 |
| 30 Sep 18 | 1 | -10 | 7 | 0 |
| 30 Jun 18 | 1 | -10 | 6 | 0 |
| 31 Mar 18 | 0 | -4 | 4 | 0 |
| 31 Dec 17 | 0 | -6 | 6 | 0 |
| 31 Dec 16 | 0 | -1 | 1 | 0 |
質の高い収益: OMIC is currently unprofitable.
利益率の向上: OMIC is currently unprofitable.
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: OMIC is unprofitable, but has reduced losses over the past 5 years at a rate of 1.5% per year.
成長の加速: Unable to compare OMIC's earnings growth over the past year to its 5-year average as it is currently unprofitable
収益対業界: OMIC is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (109.7%).
株主資本利益率
高いROE: OMIC has a negative Return on Equity (-11.58%), as it is currently unprofitable.